327 related articles for article (PubMed ID: 17272500)
1. Q2ChIP, a quick and quantitative chromatin immunoprecipitation assay, unravels epigenetic dynamics of developmentally regulated genes in human carcinoma cells.
Dahl JA; Collas P
Stem Cells; 2007 Apr; 25(4):1037-46. PubMed ID: 17272500
[TBL] [Abstract][Full Text] [Related]
2. Chromatin states of developmentally-regulated genes revealed by DNA and histone methylation patterns in zebrafish embryos.
Lindeman LC; Winata CL; Aanes H; Mathavan S; Alestrom P; Collas P
Int J Dev Biol; 2010; 54(5):803-13. PubMed ID: 20336603
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic analysis of human embryonic carcinoma cells during retinoic acid-induced neural differentiation.
Shahhoseini M; Taei A; Mehrjardi NZ; Salekdeh GH; Baharvand H
Biochem Cell Biol; 2010 Jun; 88(3):527-38. PubMed ID: 20555394
[TBL] [Abstract][Full Text] [Related]
4. Regulation of transcription of the steroidogenic acute regulatory protein (StAR) gene: temporal and spatial changes in transcription factor binding and histone modification.
Hiroi H; Christenson LK; Strauss JF
Mol Cell Endocrinol; 2004 Feb; 215(1-2):119-26. PubMed ID: 15026184
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract.
Freberg CT; Dahl JA; Timoskainen S; Collas P
Mol Biol Cell; 2007 May; 18(5):1543-53. PubMed ID: 17314394
[TBL] [Abstract][Full Text] [Related]
6. Histone modification in constitutive heterochromatin versus unexpressed euchromatin in human cells.
Jiang G; Yang F; Sanchez C; Ehrlich M
J Cell Biochem; 2004 Oct; 93(2):286-300. PubMed ID: 15368356
[TBL] [Abstract][Full Text] [Related]
7. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells.
Abbosh PH; Montgomery JS; Starkey JA; Novotny M; Zuhowski EG; Egorin MJ; Moseman AP; Golas A; Brannon KM; Balch C; Huang TH; Nephew KP
Cancer Res; 2006 Jun; 66(11):5582-91. PubMed ID: 16740693
[TBL] [Abstract][Full Text] [Related]
8. Myc-binding-site recognition in the human genome is determined by chromatin context.
Guccione E; Martinato F; Finocchiaro G; Luzi L; Tizzoni L; Dall' Olio V; Zardo G; Nervi C; Bernard L; Amati B
Nat Cell Biol; 2006 Jul; 8(7):764-70. PubMed ID: 16767079
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic characterization of the early embryo with a chromatin immunoprecipitation protocol applicable to small cell populations.
O'Neill LP; VerMilyea MD; Turner BM
Nat Genet; 2006 Jul; 38(7):835-41. PubMed ID: 16767102
[TBL] [Abstract][Full Text] [Related]
10. Developmental changes in DNA methylation and covalent histone modifications of chromatin associated with the epsilon-, gamma-, and beta-globin gene promoters in Papio anubis.
Lavelle D; Vaitkus K; Hankewych M; Singh M; DeSimone J
Blood Cells Mol Dis; 2006; 36(2):269-78. PubMed ID: 16527500
[TBL] [Abstract][Full Text] [Related]
11. Using ChIP-based technologies to identify epigenetic modifications in disease-relevant cells.
Falk J
IDrugs; 2010 Mar; 13(3):169-74. PubMed ID: 20191433
[TBL] [Abstract][Full Text] [Related]
12. MUC1 expression is regulated by DNA methylation and histone H3 lysine 9 modification in cancer cells.
Yamada N; Nishida Y; Tsutsumida H; Hamada T; Goto M; Higashi M; Nomoto M; Yonezawa S
Cancer Res; 2008 Apr; 68(8):2708-16. PubMed ID: 18413738
[TBL] [Abstract][Full Text] [Related]
13. MicroChIP: chromatin immunoprecipitation for small cell numbers.
Dahl JA; Collas P
Methods Mol Biol; 2009; 567():59-74. PubMed ID: 19588085
[TBL] [Abstract][Full Text] [Related]
14. Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis.
Hinshelwood RA; Huschtscha LI; Melki J; Stirzaker C; Abdipranoto A; Vissel B; Ravasi T; Wells CA; Hume DA; Reddel RR; Clark SJ
Cancer Res; 2007 Dec; 67(24):11517-27. PubMed ID: 18089780
[TBL] [Abstract][Full Text] [Related]
15. Essential role of C/EBPalpha in G-CSF-induced transcriptional activation and chromatin modification of myeloid-specific genes.
Iida S; Watanabe-Fukunaga R; Nagata S; Fukunaga R
Genes Cells; 2008 Apr; 13(4):313-27. PubMed ID: 18363963
[TBL] [Abstract][Full Text] [Related]
16. Constitutive promoter occupancy by the MBF-1 activator and chromatin modification of the developmental regulated sea urchin alpha-H2A histone gene.
Di Caro V; Cavalieri V; Melfi R; Spinelli G
J Mol Biol; 2007 Feb; 365(5):1285-97. PubMed ID: 17134720
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
[TBL] [Abstract][Full Text] [Related]
18. Quantitative chromatin immunoprecipitation (Q-ChIP) applied to Schistosoma mansoni.
Caby S; Pierce RJ
Mol Biochem Parasitol; 2009 Jul; 166(1):77-80. PubMed ID: 19428676
[TBL] [Abstract][Full Text] [Related]
19. H3K9 acetylation and radial chromatin positioning.
Strasák L; Bártová E; Harnicarová A; Galiová G; Krejcí J; Kozubek S
J Cell Physiol; 2009 Jul; 220(1):91-101. PubMed ID: 19248079
[TBL] [Abstract][Full Text] [Related]
20. Identifying transcriptional regulatory regions using reporter genes and DNA-protein interactions by chromatin immunoprecipitation.
Ooi L; Wood IC
Methods Mol Biol; 2008; 491():3-17. PubMed ID: 18998080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
